Please login to the form below

Not currently logged in
Email:
Password:

Life

This page shows the latest Life news and features for those working in and with pharma, biotech and healthcare.

Precision Medicine Group acquires Ethos

Precision Medicine Group acquires Ethos

With this addition, Precision has enhanced our proficiency in demonstrating the clinical value of medical innovations throughout the entire development and commercial life cycle.”.

Latest news

More from news
Approximately 63 fully matching, plus 1,124 partially matching documents found.

Latest Intelligence

  • Indefinable, incomparable and enduring: the value of creativity Indefinable, incomparable and enduring: the value of creativity

    Today it’s a whole new ball game. “Creativity is much broader than the tactics of a marketing campaign, ”says Aaron Bean, Life Sciences, EY UK &Ireland.

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    The recent Government Race Disparity Audit was evidence of the impact of inequality for people from diverse backgrounds across aspects of life and companies must now ensure their recruitment and retention

  • Is flexible working the future?

    work-life balance is soaring among staff, many healthcare communications companies are reviewing their approach to flexible working. ... of traditional agency/office life: the chit-chat, endless – sometimes pointless – meetings and mountains of admin.

  • Doing more with less: when ‘client-centricity’ matters most Doing more with less: when ‘client-centricity’ matters most

    Doing more with less: when ‘ client-centricity’ matters most. At a time when companies face continued downward pressure on operational expenditure, doing ‘more with less’is becoming a fact of life.

  • ‘How is your day?’ ‘How is your day?’

    They bring life-saving treatment to patients worldwide who live with these conditions. ... Yet, despite the life-changing impact that plasma proteins bring patients, they are not so visible on the global health landscape.

More from intelligence
Approximately 19 fully matching, plus 368 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Industry round up: appointments. Destiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams. ... Sir Nigel Rudd, chairman of Destiny Pharma, said: “Rodgers’experience of guiding growth companies, and in particular those in the

  • Weekly industry appointments Weekly industry appointments

    Abcam appoints Peter Allen as non-executive chairman. Life sciences research tools supplier Abcam has appointed Peter Allen (pictured) as its non-executive chairman, a role he assumes from Louise Patten, ... Allen has over 20 years’experience as an

  • Sue Mahony to retire as president of Lilly Oncology Sue Mahony to retire as president of Lilly Oncology

    We make medicines that help patients with cancer live longer and what a privilege it’s been to wake up each morning with that as my life’s work.”.

  • Axovant poaches Allergan’s and Teva’s chief medical and science officers Axovant poaches Allergan’s and Teva’s chief medical and science officers

    development. “We have a wonderful opportunity to develop life-changing medicines for patients with CNS diseases.

  • Kevin Sin joins GSK Kevin Sin joins GSK

    Sin joins GSK from Genetech, where he served as vice president and global head of oncology business development and has worked within the pharmaceutical and life science industry for over 20

More from appointments
Approximately 32 fully matching, plus 338 partially matching documents found.

Latest from PMHub

  • Data Visualisation

    Special guests from Bluedog – a creative design and branding agency – presented some of their most recent works using data visualisation techniques – bringing this complex topic to life.

  • The True Potential of Mobile Health Tech

    life. We can try to collect the data through the clinic or digital media all we like but if patients are not engaged with the disease and don’ t understand the

  • Developing advocacy in the pharmaceutical industry.

    It should also be remembered that advocacy development and usage are not just reserved for launch; rather, they should be valued throughout the life cycle of the product and thus managed ... appropriately and within the scope of their own life cycle (see

  • This year’s winner of the emotive. Prize for Scientific Engagement!

    At emotive. we aim to inspire students about life sciences and offer opportunities for them to explore careers within healthcare communications.

  • Training the next generation of biotech leaders

    graduation. The life sciences sector is a very diverse ecosystem. You need different flavours of graduates and skillsets, according to the different areas people are working in. ... It brings engineers and people from the life sciences sector into the

More from PMHub
Approximately 15 fully matching, plus 627 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics